NDT Advance Access originally published online on June 14, 2005
Nephrology Dialysis Transplantation 2005 20(9):1898-1903; doi:10.1093/ndt/gfh933
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MIBI scintigraphy, indicators of cell proliferation and histology of parathyroid glands in uraemic patients
1 Nephrology Division, 2 Head and Neck Surgery and 3 Nuclear Medicine, University of São Paulo School of Medicine, São Paulo and 4 Nephrology Division, University of Uberlândia, Minas Gerais, Brazil
Correspondence and offprint requests to: Vanda Jorgetti, MD, PhD, Renal Physiopathology Laboratory (LIM-16), University of São Paulo School of Medicine, Av. Dr Arnaldo, 455-Sala 3342, São Paulo, SP 01246-903, Brazil. Email: vandajor{at}usp.br
Background. Although scintigraphy with 99mTc-sestamibi (MIBI) has been used to localize parathyroid glands prior to surgery for hyperparathyroidism, using it to evaluate parathyroid function remains controversial. The purpose of this study was to evaluate the possible association of MIBI uptake with gland weight, histological pattern and proliferative activity of parathyroid cells.
Methods. We studied 18 patients with secondary hyperparathyroidism (SHP); mean age 38±3 years, 55% female, mean time on haemodialysis 7.7±0.9 years. All patients had parathyroidectomy (PTx). The weights of the removed glands were estimated, and parathyroid hyperplasia was classified as diffuse (n = 28) or nodular (n = 29). The expression of proliferative cell nuclear antigen (PCNA) was evaluated by immunohistochemistry. Before PTx, all patients underwent MIBI evaluation and were categorized using a 0–3 uptake scoring system. Low uptake (scores of 0 and 1) was seen in 39 glands and high uptake (scores of 2 and 3) in 18.
Results. Estimated gland weights, percentage of nodular hyperplasia and PCNA expression were greater in glands with high MIBI scores than in those with low scores (P<0.01). In glands with nodular hyperplasia, PCNA expression was higher (318±66 cells/mm2) than in those with diffuse hyperplasia (104±16 cells/mm2; P<0.001).
Conclusions. High MIBI scores were associated with high estimated gland weight, degree of cell proliferation and presence of nodular hyperplasia. MIBI scintigraphy is useful in clinical practice for localizing parathyroid glands, and it could guide the management of SHP by indicating the degree of its severity.
Keywords: end-stage renal disease; hyperparathyroidism; MIBI; parathyroid glands; PCNA; 99mTc-sestamibi
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Komaba and M. Fukagawa Regression of parathyroid hyperplasia by calcimimetics--fact or illusion? Nephrol. Dial. Transplant., March 1, 2009; 24(3): 707 - 709. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lomonte, L. Vernaglione, D. Chimienti, A. Bruno, S. Cocola, A. Teutonico, F. Cazzato, and C. Basile Does Vitamin D Receptor and Calcium Receptor Activation Therapy Play a Role in the Histopathologic Alterations of Parathyroid Glands in Refractory Uremic Hyperparathyroidism? Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 794 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Basile, C. Lomonte, L. Vernaglione, F. Casucci, D. Chimienti, A. Bruno, S. Cocola, E. A. Verrelli, and F. Cazzato A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia Nephrol. Dial. Transplant., April 1, 2006; 21(4): 968 - 974. [Abstract] [Full Text] [PDF]
|
|